OmniAb, Inc. (OABI) vs Verastem, Inc. (VSTM)
OmniAb, Inc. and Verastem, Inc. are both Biotechnology companies. OmniAb, Inc. and Verastem, Inc. are of similar size ($697.9M and $694.6M). Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against 67.0%. OmniAb, Inc. has the higher net margin (−115.1% vs −231.6%) and the lower return on invested capital (−14.5% vs 0.00%). Across the 17 metrics below, OmniAb, Inc. leads on 11 and Verastem, Inc. on 6.
Valuation
Profitability
| Metric | OABI | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.28% | 86.35% | 65.16% |
| Operating margin | (125.78%) | (182.57%) | 0.00% |
| Net margin | (115.12%) | (231.59%) | 0.00% |
| Free cash flow margin | (47.17%) | (185.31%) | 0.00% |
| Return on equity | (16.95%) | (471.16%) | (57.72%) |
| Return on assets | (15.11%) | (100.65%) | (49.22%) |
| Return on invested capital | (14.52%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack